Zika virus: History, emergence, biology, and prospects for control

Scott Weaver, Federico Costa, Mariano Garcia-Blanco, Albert I. Ko, Guilherme S. Ribeiro, George Saade, Pei-Yong Shi, Nikos Vasilakis

Research output: Contribution to journalArticle

293 Citations (Scopus)

Abstract

Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. After its putative evolution in sub-Saharan Africa, ZIKV spread in the distant past to Asia and has probably emerged on multiple occasions into urban transmission cycles involving Aedes (Stegomyia) spp. mosquitoes and human amplification hosts, accompanied by a relatively mild dengue-like illness. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice relatively rare congenital microcephaly and Guillain-Barré syndromes. Another hypothesis is that phenotypic changes in Asian lineage ZIKV strains led to these disease outcomes. Here, we review potential strategies to control the ongoing outbreak through vector-centric approaches as well as the prospects for the development of vaccines and therapeutics.

Original languageEnglish (US)
Pages (from-to)69-80
Number of pages12
JournalAntiviral Research
Volume130
DOIs
StatePublished - Jun 1 2016

Fingerprint

Dengue
History
Disease Outbreaks
Micronesia
Yellow fever virus
Japanese Encephalitis
Flavivirus
Microcephaly
South America
Aedes
Africa South of the Sahara
Culicidae
Vaccines
Zika Virus
Therapeutics
Zika Virus Infection

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Zika virus : History, emergence, biology, and prospects for control. / Weaver, Scott; Costa, Federico; Garcia-Blanco, Mariano; Ko, Albert I.; Ribeiro, Guilherme S.; Saade, George; Shi, Pei-Yong; Vasilakis, Nikos.

In: Antiviral Research, Vol. 130, 01.06.2016, p. 69-80.

Research output: Contribution to journalArticle

@article{cfdb0df4be10464581ae93c549761370,
title = "Zika virus: History, emergence, biology, and prospects for control",
abstract = "Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. After its putative evolution in sub-Saharan Africa, ZIKV spread in the distant past to Asia and has probably emerged on multiple occasions into urban transmission cycles involving Aedes (Stegomyia) spp. mosquitoes and human amplification hosts, accompanied by a relatively mild dengue-like illness. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice relatively rare congenital microcephaly and Guillain-Barr{\'e} syndromes. Another hypothesis is that phenotypic changes in Asian lineage ZIKV strains led to these disease outcomes. Here, we review potential strategies to control the ongoing outbreak through vector-centric approaches as well as the prospects for the development of vaccines and therapeutics.",
author = "Scott Weaver and Federico Costa and Mariano Garcia-Blanco and Ko, {Albert I.} and Ribeiro, {Guilherme S.} and George Saade and Pei-Yong Shi and Nikos Vasilakis",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.antiviral.2016.03.010",
language = "English (US)",
volume = "130",
pages = "69--80",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",

}

TY - JOUR

T1 - Zika virus

T2 - History, emergence, biology, and prospects for control

AU - Weaver, Scott

AU - Costa, Federico

AU - Garcia-Blanco, Mariano

AU - Ko, Albert I.

AU - Ribeiro, Guilherme S.

AU - Saade, George

AU - Shi, Pei-Yong

AU - Vasilakis, Nikos

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. After its putative evolution in sub-Saharan Africa, ZIKV spread in the distant past to Asia and has probably emerged on multiple occasions into urban transmission cycles involving Aedes (Stegomyia) spp. mosquitoes and human amplification hosts, accompanied by a relatively mild dengue-like illness. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice relatively rare congenital microcephaly and Guillain-Barré syndromes. Another hypothesis is that phenotypic changes in Asian lineage ZIKV strains led to these disease outcomes. Here, we review potential strategies to control the ongoing outbreak through vector-centric approaches as well as the prospects for the development of vaccines and therapeutics.

AB - Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. After its putative evolution in sub-Saharan Africa, ZIKV spread in the distant past to Asia and has probably emerged on multiple occasions into urban transmission cycles involving Aedes (Stegomyia) spp. mosquitoes and human amplification hosts, accompanied by a relatively mild dengue-like illness. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice relatively rare congenital microcephaly and Guillain-Barré syndromes. Another hypothesis is that phenotypic changes in Asian lineage ZIKV strains led to these disease outcomes. Here, we review potential strategies to control the ongoing outbreak through vector-centric approaches as well as the prospects for the development of vaccines and therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=84962877705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962877705&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2016.03.010

DO - 10.1016/j.antiviral.2016.03.010

M3 - Article

C2 - 26996139

AN - SCOPUS:84962877705

VL - 130

SP - 69

EP - 80

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

ER -